The compliance Leadership Roundtable

Meet the thought leaders, talk to them, and join them in live conversations.

Last updated: February 17, 2025

Edoardo Lazzarini

Former Senior Ethics & Compliance Officer, Southern Europe (Italy, Spain, Portugal)
Haleon | TAKEDA

Read more
Edoardo, formerly a MedTech compliance officer, brings over 25 years of expertise in compliance and transparency. A recognized thought leader, Edoardo has led ethics programs across top pharmaceutical companies and offers strategic insights into Italian compliance practices.

 

Recent Engagements

  • Actively running Discovery Programs with 20 pharmaceutical companies, 10 medical device companies, 3 labs, and 1 cosmetics company.
  • Transparency Reporting Workshop – Milan – December 17, 2024
  • Hands-on Workshop: From Spend to Telematic Register – Milan – November 12, 2024
  • Italian Sunshine Report: Hands-on Workshop by Experts – Milan – October 14, 2024

 

Upcoming Events

  • Community Event – Milan – February 26th, 2025

Ned Mumtaz

Former Director, Transparency Operations, Commercial and R&D

PFIZER | OTSUKA

Read more
Ned is a global expert in transparency reporting with extensive experience producing high-quality, compliant reports for over 150 international pharmaceutical companies. He has held leadership positions at Pfizer and Otsuka and is renowned for his work in delivering precise and reliable reports.

 

Recent Engagements

  • Transparency Reporting Workshop – Milan – December 17, 2024
  • Hands-on Workshop: From Spend to Telematic Register – Milan – November 12, 2024
  • Italian Sunshine Report: Hands-on Workshop by Experts – Milan – October 14, 2024

 

Upcoming Events

  • Community Event – Milan – February 26th, 2025

Q1. For a business leader like a CEO of a biotech company or a Medical Director of a Medical Group Practice, how would you describe the new Italian Sunshine Law? Its risk? Its exposure? & key steps for the leader to consider?

For a business leader like a CEO of a biotech company or a Medical Director of a Medical Group Practice, how would you describe the new Italian Sunshine Law? Its risk? Its exposure? & key steps for the leader to consider?
For a business leader like a CEO of a biotech company or a Medical Director of a Medical Group Practice, how would you describe the new Italian Sunshine Law? Its risk? Its exposure? & key steps for the leader to consider?
For a business leader like a CEO of a biotech company or a Medical Director of a Medical Group Practice, how would you describe the new Italian Sunshine Law? Its risk? Its exposure? & key steps for the leader to consider?
For a business leader like a CEO of a biotech company or a Medical Director of a Medical Group Practice, how would you describe the new Italian Sunshine Law? Its risk? Its exposure? & key steps for the leader to consider?
M
Advertisement